NOXOA
Noxopharm Limited
🇦🇺 ASX
👑 Overview
📈 Performance
💵 Cost
🤓 Advanced
👨👩👧👦 Community
📈
+ 2.40%
Annual Growth
4 years average annual growth
💵
$ 500
Minimum Order
Due to regulatory requirements
🌏
0
Pearlers Invested
Since January 2020
👑 Overview
Key information
🔎 Fund Overview
Noxopharm Limited - Option Expiring 14-Aug-2023
📈 Performance
Price History
+9.89%
1M
All Time
Graph
Table
Unsure how much or often to invest?
🗓️ Investing frequency calculator
Determine the investment frequency needed to reach your goals
Try it out →💵 Investing amount calculator
Determine the recurring investment needed to reach your goals
Try it out →⏱️ Investing duration calculator
Determine how long you will need to invest to reach your goals
Try it out →💵 Costs
💼
0%
Management Fee
Included in unit price, not charged by Pearler
💸
Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator🤓 Advanced information
Technical Info
💰 Price*
$0.10
*Price may be up to 24 hours old
👩👩👦 Community Insights
How our community is investing
🌏 Pearlers invested in NOXOA
0
📊 Total Capital Earnings
N/A
🔃 Average investment frequency
N/A
💵 Average investment amount
N/A
⏰ Last time a customer invested in NOXOA
N/A
NOXOA investor breakdown
💵 Income of investors
More than 200k
150k - 200k
100k - 150k
50k - 100k
Less than 50k
👶 Age of investors
18 - 25
26 - 34
35 - 90
🙋 Legal gender of investors
Female
Male
Pearlers who invest in NOXOA also invest in...
Want more shares? Try these...
NewPeak Metals Ltd. engages in coal and lithium exploration in Argentina, oil and gas in Australia, and gold exploration in U.S. Its projects include cachi gold, san Jorge lithium brine and las openas gold. The company is headquartered in Brisbane, Queensland. The company went IPO on 2011-04-11. The firm is focused on discovering a multimillion-ounce gold deposit. The firm is engaged in holding strategic positions in several gold properties in jurisdictions, including Finland, New Zealand, and Argentina, together with Tungsten projects in Sweden. Its suite of Southern Finland projects lies in a region, which hosts three gold mines (Orivesi, Jokisivu and Kaapelinkulma) with a processing facility at Vammala. The firm holds interest in Cachi Gold Project and Las Openas Gold Project in Argentina. The Cachi Gold Project is an approximately 46,892 hectares (ha) lease package located in the central-western region of Santa Cruz Province, Argentina. The Las Openas Gold Project is located in the mining province of San Juan. The company also has an interest in Cap Burn Gold Project, in Otago, New Zealand and the Santana-Matakanui Bendigo-Ophir project in the west. The company has the Sweden Strategic Metals Project in Sweden.
📊 Share price
$0.00 AUD
Noxopharm Ltd. engages in the research and development of drugs. The company is headquartered in Gordon, New South Wales. The company went IPO on 2016-08-09. The firm is engaged in the discovery and development of treatments for cancer and inflammation. The firm has three active drug development programs: its clinical drug candidate Veyonda, plus two technology platforms, Chroma (oncology) and Sofra (inflammation and autoimmunity), which provide the basis for the active development of a growing pipeline of drugs. Veyonda (Idronoxil) is an adjuvant therapy in chemotherapy and radiotherapy in the treatment of late-stage cancers. The Chroma drug candidates have bioactive properties, which it is exploring primarily in the anti-cancer space. Its Sofra platform is centered around short nucleic acid sequences called oligonucleotides, which can act on specific cell receptors to stop inflammation, which is a source of various debilitating and lethal diseases. The company is also conducting a dose escalation and dose expansion study of NOX66 in the treatment of COVID-19 infection.
📊 Share price
